EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Collaxio B (COLLAX) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Collaxio B SEK 0.73, price SEK 0.45, upside +62.8%, quality 31 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Financial Services · SE

CB Thin data Sep 23, 2026

Collaxio B

COLLAX · ST

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value kr 0.7310 · Strongly undervalued (+63%)
!Quality 31/100
!Weak Growth (revenue YoY −72.2 %/yr)
!negative free cash flow
!Trails peers (2/8)
!Narrow moat 17/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 1.12 kr 0.4200 Fair Value kr 0.7310 Oct 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 23, 2026.

How to read this chart

11‑month range kr 0.4200 – kr 1.12 · fair‑value band kr 0.5440 – kr 0.9095 · the kr 0.4490 price screens below the kr 0.7310 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Sep 23, 2026.

Follow Collaxio B in your weekly email

Every Wednesday you see whether Collaxio B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Collaxio AB (publ) is a private equity, venture capital and secondary (direct) firm specializing in acquisitions & buy-and-build investments. It prefers to invest in four key sectors-B2B/SaaS & platform solutions, quality of life, transformational shifts and opportunistic.

Show more

Collaxio AB (publ) is a private equity, venture capital and secondary (direct) firm specializing in acquisitions & buy-and-build investments. It prefers to invest in four key sectors-B2B/SaaS & platform solutions, quality of life, transformational shifts and opportunistic. It prefers to have a board representation and advisory board seats in its portfolio companies. Collaxio AB (publ) was founded in 2025 and is based in Stockholm, Sweden with additional offices in Shanghai, China.

Stock analysis

Collaxio B (COLLAX) currently trades at kr 0.4490, while our model-based Fair Value estimate is kr 0.7310, implying the stock looks roughly 38.6% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 91/100, which puts the evidence level at low.

Scenario range: kr 0.5440 (bear) to kr 0.9095 (bull), the price of kr 0.4490 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Financial Services sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Collaxio B reported revenue of 944K SEK in FY2025 versus −23.0M SEK in FY2022. Reported net income was −35.4M SEK in FY2025.

Key figures

Market cap 43.4M SEK (≈ $4.4M) · EPS (TTM) kr −0.5800 · Return on equity −28.5% · Return on assets (EBIT) −28.9% · Operating margin 4.6% · Revenue (TTM) −10.4M SEK · Free cash flow −15.3M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

For context, the median of 10 Financial Services peers we cover trades at −4% fair-value upside, at 63%, COLLAX screens cheaper than that median.

Fair Value models

Bear kr 0.5440 Fair Value kr 0.7310 Bull kr 0.9095
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
P/B Multiple kr 0.6500 kr 0.8700 kr 1.09 55
NCAV (Graham) kr 0.5100 kr 0.6800 kr 1.02 51
All 2 models by family
Multiples
P/B Multiple kr 0.6500 kr 0.8700 kr 1.09 55
Asset-Based
NCAV (Graham) kr 0.5100 kr 0.6800 kr 1.02 51

Open the full fair value analysis →

Notify me when COLLAX reaches fair value

Put COLLAX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 31/100

Of which business quality 38 · Market factors (momentum, volatility) 26

Profitability 0
Margins and returns on capital today
Quality Growth 10
Are margins and returns improving?
Cashflow 25
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 47
Calm price path (market factor)
Momentum 26
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch COLLAX, get fair value alerts →

Compare Collaxio B with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 657 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside +62% · Above median
Profitability
Return on assets −16% · Bottom 25%
Operating margin (TTM) 5% · Bottom 25%
Growth and dividend
Revenue growth 0% · Below median
Dividend yield (TTM) 0.0% · Bottom 25%

Valuation Multiplesvs Asset Management median · lower = cheaper

P/B 0.05× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 54
FUTURE (revenue growth)0 · sector 21
PAST (return on equity)0 · sector 23
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)0 · sector 81

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Blackstone Inc BX $124.01 $52.88 −57%
Brookfield Corporation BN $37.85 $13.75 −64%
KKR & Co KKR $97.21 $29.25 −70%
Apollo Global Management, Inc APO $124.36 $229.64 +85%
State Street Corporation STT $179.95 $138.33 −23%
Ameriprise Financial, Inc AMP $502.79 $579.51 +15%
Ares Management Corporation ARES $124.72 $119.25 −4%
Northern Trust Corporation NTRS $173.40 $122.02 −30%
Raymond James Financial, Inc RJF $158.23 $312.27 +97%
T. Rowe Price Group TROW $104.57 $209.14 +100%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Collaxio B Fair Value". https://www.fairvalue-calculator.com/stock/COLLAX

Frequently asked questions

Is Collaxio B (COLLAX) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of kr 0.7310 versus a price of kr 0.4490, about +63% upside (undervalued).
What is the fair value of COLLAX?
Our model-based fair value for Collaxio B is kr 0.7310 (as of Sep 23, 2026), built from audited fundamentals. The current price: kr 0.4490.
What is the quality score of COLLAX?
Collaxio B has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Collaxio B (COLLAX)?
Our model-based price target is the fair value of kr 0.7310 (as of Sep 23, 2026) from 2 valuation models. Cautious scenario kr 0.5440, optimistic scenario kr 0.9095. It is a calculation from audited fundamentals, not an analyst target.
What is the Collaxio B stock forecast for 2026?
Our models put fair value at kr 0.7310, about +63% upside versus a price of kr 0.4490 (undervalued). Cautious scenario kr 0.5440, optimistic scenario kr 0.9095. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Collaxio B (COLLAX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Collaxio B it is kr 0.7310 per share (as of Sep 23, 2026), against a price of kr 0.4490. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Collaxio B stock overvalued or undervalued in 2026?
As of Sep 23, 2026, COLLAX trades below its calculated fair value: price kr 0.4490, fair value kr 0.7310, a gap of about +63% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of COLLAX?
No. The price is what the market pays today (kr 0.4490); the fair value is what the company's own numbers justify (kr 0.7310). For Collaxio B the two are kr 0.2820 per share apart. That gap is exactly why we show both numbers side by side.
How much is Collaxio B worth?
The market values Collaxio B at about 43.4M SEK (market capitalisation, as of Sep 23, 2026). Per share that is kr 0.4490; our models calculate a fair value of kr 0.7310 per share.
What do the bullish and bearish scenarios say about COLLAX?
Our models span a range for Collaxio B: cautious scenario kr 0.5440, base kr 0.7310, optimistic kr 0.9095 per share (as of Sep 23, 2026, price kr 0.4490). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Collaxio B (COLLAX)?
Balance-sheet figures for Collaxio B (as of Sep 23, 2026): return on equity −28.5%. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
Which stocks are comparable to Collaxio B?
From the same area (Financial Services) we also value Blackstone Inc, Brookfield Corporation, KKR & Co, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Collaxio B stock attractive at the current price?
The data as of Sep 23, 2026: price kr 0.4490, calculated fair value kr 0.7310 (+63%), Quality Score 31/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of COLLAX calculated?
We run Collaxio B through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.7310, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Collaxio B currently trades 63 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Collaxio B (COLLAX)?
The closing price on Sep 24, 2026 was kr 0.4490. Our model-based fair value is kr 0.7310, about +63% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Collaxio B right now?
The large discount to fair value meets weak quality (31/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (kr 0.5440). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of Collaxio B

How large is the market capitalisation of Collaxio B (COLLAX)?
The market capitalisation of Collaxio B is 43.4M SEK (≈ $4.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Collaxio B (COLLAX)?
Earnings per share at Collaxio B are kr −0.5800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Collaxio B (COLLAX)?
The return on equity (ROE) of Collaxio B is −28.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Collaxio B (COLLAX)?
On an EBIT basis the return on assets of Collaxio B is −28.9% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Collaxio B (COLLAX)?
The operating margin of Collaxio B is 4.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much revenue does Collaxio B (COLLAX) generate?
Collaxio B generates revenue of −10.4M SEK (last twelve months). Revenue of the last twelve months (TTM), the most recent full year, not the calendar year.
How much free cash flow does Collaxio B (COLLAX) generate?
The free cash flow of Collaxio B is −15.3M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Collaxio B in the live analysis

One click puts Collaxio B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.